Weixing Shen

2.7k total citations
94 papers, 1.7k citations indexed

About

Weixing Shen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weixing Shen has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 19 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Weixing Shen's work include Traditional Chinese Medicine Analysis (6 papers), Pharmacological Effects of Natural Compounds (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Weixing Shen is often cited by papers focused on Traditional Chinese Medicine Analysis (6 papers), Pharmacological Effects of Natural Compounds (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Weixing Shen collaborates with scholars based in China, Macao and United States. Weixing Shen's co-authors include Haibo Cheng, Jiani Tan, Changliang Xu, Dongdong Sun, Qibiao Wu, Xiaoyan Shen, Liu Li, Bing‐Mei Zhu, Faiyaz Ahmad and Matthew A. Movsesian and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Weixing Shen

83 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weixing Shen China 24 865 252 207 203 191 94 1.7k
Zhaoguo Liu China 28 915 1.1× 208 0.8× 271 1.3× 231 1.1× 172 0.9× 64 2.0k
Vijaya Padma Viswanadha India 27 1.1k 1.3× 215 0.9× 309 1.5× 170 0.8× 139 0.7× 95 2.2k
Yangyang Hu China 20 869 1.0× 189 0.8× 216 1.0× 314 1.5× 306 1.6× 53 2.1k
Yueh-Min Lin Taiwan 25 649 0.8× 184 0.7× 184 0.9× 290 1.4× 125 0.7× 62 1.4k
Cecilia Hsuan Day Taiwan 24 786 0.9× 167 0.7× 183 0.9× 160 0.8× 111 0.6× 75 1.7k
Marthandam Asokan Shibu Taiwan 24 957 1.1× 170 0.7× 246 1.2× 135 0.7× 99 0.5× 98 1.9k
Wenqun Li China 22 712 0.8× 131 0.5× 163 0.8× 161 0.8× 109 0.6× 58 1.5k
Kailin Yang China 26 757 0.9× 278 1.1× 193 0.9× 135 0.7× 210 1.1× 103 2.1k
Yue Jin China 25 881 1.0× 139 0.6× 174 0.8× 132 0.7× 231 1.2× 44 1.8k

Countries citing papers authored by Weixing Shen

Since Specialization
Citations

This map shows the geographic impact of Weixing Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixing Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixing Shen more than expected).

Fields of papers citing papers by Weixing Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weixing Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixing Shen. The network helps show where Weixing Shen may publish in the future.

Co-authorship network of co-authors of Weixing Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Weixing Shen. A scholar is included among the top collaborators of Weixing Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixing Shen. Weixing Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shubo, Ziming Zhao, Lili Yu, et al.. (2025). Identification of Quercetin as a Natural MMP1 Inhibitor for Overcoming Cisplatin Resistance in Epithelial Ovarian Cancer. Journal of Cancer. 16(8). 2578–2594.
2.
3.
4.
Wang, Jin, et al.. (2025). α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation. Journal of Pharmaceutical Analysis. 15(12). 101301–101301.
5.
6.
7.
Shen, Weixing & Barbara T.H. Yen. (2025). Critical factors influenced pedestrian walking speed: A meta-analysis. Research in Transportation Economics. 111. 101564–101564. 1 indexed citations
8.
Zhang, Y., Meng Shen, Jie Jin, et al.. (2025). Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis. Phytomedicine. 148. 157366–157366. 1 indexed citations
9.
Yang, Xueying, Zhiyu Li, Qianyu Wang, et al.. (2025). Huangqi Guizhi Wuwu decoction alleviate Oxaliplatin-Induced Peripheral Neuropathy by adjusting the myelin regeneration. Phytomedicine. 145. 157039–157039.
10.
Hu, Yiran, Qingyao Ai, Ning Zheng, et al.. (2024). STARD: A Chinese Statute Retrieval Dataset Derived from Real-life Queries by Non-professionals. 10658–10671. 3 indexed citations
11.
Hou, Dahai, Liu Li, Weixing Shen, et al.. (2024). Curcumol promotes ferroptosis of colon cancer by targeting the ubiquitination and degradation of GPX4. Journal of Traditional and Complementary Medicine. 15(2). 170–181. 2 indexed citations
12.
Li, Ziwen, Yueyang Lai, Jianrong Liu, et al.. (2024). α‐Hederin induces paraptosis by targeting GPCRs to activate Ca2+/MAPK signaling pathway in colorectal cancer. Cancer Medicine. 13(8). e7202–e7202. 10 indexed citations
13.
14.
Yao, Feng, Jingyuan Zhang, Yating Zhang, et al.. (2023). Unsupervised Legal Evidence Retrieval via Contrastive Learning with Approximate Aggregated Positive. Proceedings of the AAAI Conference on Artificial Intelligence. 37(4). 4783–4791. 1 indexed citations
15.
Tan, Jiani, Qijuan Wang, Tingting Zhou, et al.. (2023). α-hederin regulates glucose metabolism in intestinal epithelial cells by increasing SNX10 expression. Phytomedicine. 111. 154677–154677. 3 indexed citations
16.
17.
Feng, Yong, Chaojun Xiao, Lei Hou, et al.. (2022). LEVEN: A Large-Scale Chinese Legal Event Detection Dataset. Findings of the Association for Computational Linguistics: ACL 2022. 183–201. 1 indexed citations
18.
Liu, Xinyu, et al.. (2022). PPARγ Mediates Protective Effect against Hepatic Ischemia/Reperfusion Injury via NF-κB Pathway. Journal of Investigative Surgery. 35(8). 1648–1659. 10 indexed citations
19.
Sun, Dongdong, Feng Zhang, Jie Qian, et al.. (2018). 4′-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Chemico-Biological Interactions. 296. 26–33. 21 indexed citations
20.
Shen, Weixing, et al.. (2010). Study of One-stage Resection and Anastomosis on Acute Left Hemi-colon Obstruction. 17(2). 208–210.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaoguo Liu Breakdown of academic impact, for papers by Vijaya Padma Viswanadha Breakdown of academic impact, for papers by Yangyang Hu Breakdown of academic impact, for papers by Yueh-Min Lin Breakdown of academic impact, for papers by Cecilia Hsuan Day Breakdown of academic impact, for papers by Marthandam Asokan Shibu Breakdown of academic impact, for papers by Wenqun Li Breakdown of academic impact, for papers by Kailin Yang Breakdown of academic impact, for papers by Yue Jin
Rankless by CCL
2026